Cargando…

Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes

IMPORTANCE: The appropriate target of glycemic control in diabetic kidney disease is unclear. OBJECTIVE: To investigate optimal on-treatment glycemic levels associated with slowing of diabetic kidney disease progression. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducte...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jung, Hae Hyuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482057/ https://www.ncbi.nlm.nih.gov/pubmed/34586368 http://dx.doi.org/10.1001/jamanetworkopen.2021.27387

Ejemplares similares

Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline
por: Won, Ki-Bum, et al.
Publicado: (2020)

Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
por: Hubbard, Demetria, et al.
Publicado: (2021)

Analysis of Specialty Nephrology Care Among Patients With Chronic Kidney Disease and High Risk of Disease Progression
por: Wang, Maggie, et al.
Publicado: (2022)

Evaluation of the impact of glycemic status on the progression of coronary artery calcification in asymptomatic individuals
por: Won, Ki-Bum, et al.
Publicado: (2018)

Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients
por: Ibrahim, Fowzia, et al.
Publicado: (2012)

A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels
por: Schinner, Sven, et al.
Publicado: (2011)

Association of Optimal Blood Pressure With Critical Cardiorenal Events and Mortality in High-Risk and Low-Risk Patients Treated With Antihypertension Medications
por: Jung, Hae Hyuk
Publicado: (2019)

Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis
por: Kaze, Arnaud D., et al.
Publicado: (2022)

Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and the Incidence of Acute Kidney Injury in Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2023)

A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum Calcium, -magnesium and -phosphate in Type 2 diabetes and non-diabetes metabolism
por: Håglin, Lena, et al.
Publicado: (2011)

Associations of Serum Folate and Vitamin B(12) Levels With Cardiovascular Disease Mortality Among Patients With Type 2 Diabetes
por: Liu, Yujie, et al.
Publicado: (2022)

Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients
por: Hayashi, Toshio, et al.
Publicado: (2011)

Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence
por: Schechter, Meir, et al.
Publicado: (2021)

Progression and Regression of Chronic Kidney Disease by Age Among Adults in a Population-Based Cohort in Alberta, Canada
por: Liu, Ping, et al.
Publicado: (2021)

Retinopathy and Risk of Kidney Disease in Persons With Diabetes
por: Hong, Jingyao, et al.
Publicado: (2021)

Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes
por: Jung, Chang Hee, et al.
Publicado: (2015)

Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis*
por: Criado, Paulo Ricardo, et al.
Publicado: (2013)

The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data
por: Park, Byoungjin, et al.
Publicado: (2020)

Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study
por: Kim, Young-Gun, et al.
Publicado: (2018)

The Triglyceride-Glucose Index and Obesity-Related Risk of End-Stage Kidney Disease in Austrian Adults
por: Fritz, Josef, et al.
Publicado: (2021)

Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023)

Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients
por: Jung, Chan-Hee, et al.
Publicado: (2012)

Barriers and Facilitators to Home Dialysis Among Latinx Patients with Kidney Disease
por: Rizzolo, Katherine, et al.
Publicado: (2023)

Caffeic acid phenethyl amide improves glucose homeostasis and attenuates the progression of vascular dysfunction in Streptozotocin-induced diabetic rats
por: Ho, Yi-Jin, et al.
Publicado: (2013)

Metabolic Differences in Diabetic Kidney Disease Patients with Normoalbuminuria versus Moderately Increased Albuminuria
por: Hallan, Stein I., et al.
Publicado: (2023)

Association of Time-Varying Blood Pressure With Chronic Kidney Disease Progression in Children
por: Reynolds, Ben Christopher, et al.
Publicado: (2020)

Association of Serum Leptin Levels With Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes
por: Hanai, Ko, et al.
Publicado: (2011)

Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study
por: Li, Suhua, et al.
Publicado: (2020)

Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes
por: Heo, Nam Ju, et al.
Publicado: (2020)

Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease
por: Goto, Shinya, et al.
Publicado: (2020)

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
por: Nelson, Adam J., et al.
Publicado: (2022)

Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
por: Eberly, Lauren A., et al.
Publicado: (2021)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

Low serum docosahexaenoic acid is associated with progression of coronary atherosclerosis in statin-treated patients with diabetes mellitus: results of the treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH) study
por: Nozue, Tsuyoshi, et al.
Publicado: (2014)

A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease
por: Brophy, Donald F, et al.
Publicado: (2005)

Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases
por: Bramlage, Peter, et al.
Publicado: (2019)

Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in south-Asians
por: Wasim, Hanif, et al.
Publicado: (2006)

Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance
por: Choudhury, Robin P., et al.
Publicado: (2016)

Evaluation of Disease Complications Among Adults With Type 1 Diabetes and a Family History of Type 2 Diabetes in Taiwan
por: Lin, Chia-Hung, et al.
Publicado: (2021)

Fluctuations in Serum Creatinine Levels During Hospitalization and Long-Term End-Stage Kidney Disease and Mortality
por: Efros, Orly, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bl2u6pertfji2igsko3nnf0b6d